Congratulations Jesse Roman, MD, ATS Treasurer 2022 – 2025!
Jesse Roman, MD, has been voted ATS Treasurer for the 2022 – 2025 term. The position of Treasurer is critical for the ATS, as this individual will spend three years providing guidance, oversight and reporting of the Society’s finances. Dr. Roman is the first to hold this position.
Dr. Roman has been a member of the ATS since 1988, and he is committed to diversity, equity and inclusion, having served as a founding leader of the Health Equity Subcommittee within the Health Equity and Diversity Committee. He is currently with Jefferson Health in Philadelphia, Pa, where he serves as the Ludwig Kind Professor of Medicine; enterprise division chief, Pulmonary, Allergy and Critical Care Medicine; and director of the Pulmonary and Critical Care Medicine Fellowship Program. Dr. Roman also serves as CEO of the Jane & Leonard Korman Respiratory Institute of Jefferson Health and National Jewish Health.
As Treasurer, Dr. Roman intends to identify new sources for revenue generation to ensure that ATS assets are sustained and grown, to fund advancement in ATS philanthropic efforts by enhancing the work of the Funds for the Future Committee, and to support engagement in novel recruitment initiatives for new membership from around the world. He also hopes to secure new resources to support improving awareness about respiratory disease.
The new ATS Treasurer position is part of the ATS commitment to growth and improvement. Read more about the governance task force recommendations, and see the notification of proposed changes to the Bylaws.
Join Us in San Francisco at ATS 2022!
In addition to everything you've come to expect at the annual ATS International Conference – the Year in Review sessions, Scientific Symposia, and Poster discussions, Industry Theaters, Guru Bars, and the PAR Path in our Exhibit Hall – join us for in-person networking opportunities!
Kick off the conference at the biggest networking event at ATS 2022, the "Welcome Home" reception in support of the ATS Research Program! There has never been a better time to come together as a Society and support research!
If you are PhD, Basic Scientist, post-doc, or early career professional, join us at the Science and Innovations Center for a networking hour at 3 p.m. PT on May 15!
Make sure you also make time to visit us at the ATS Center for live programming throughout the conference and to learn about how you can stay connected with the Society all year! We’ll have Ask Me Anything opportunities with key ATS staff, lively discussions with prominent ATS members, and more. The ATS Center also acts as the #ATS2022 social media hub, with selfie stations and information about social media surprises throughout the conference.
As always, our top priority is to keep our attendees safe. Please review our Health & Safety Protocol to see the measures we have put in place, and verify your vaccination status in advance to save time onsite!
Register now and learn more about all the exciting opportunities at ATS 2022!
Upcoming Events
Assembly Events
The ATS Assembly on Respiratory Structure and Function, and the Drug and Device Discovery and Development Committee present, “Technology Development: Translating Innovation from Bench to Bedside Part 3: Navigating Licensing and Start-ups.”
When: 2 p.m. ET, today, April 6, 2022
Register now.
The Section on Genetics and Genomics presents, “Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease.”
When: 12:30 p.m. ET, April 7, 2022
Register now.
COVID-19 Real-Time Learning Network Clinician Call, “All About Paxlovid; Plus Update on Sotrovimab”
When: 3 p.m. ET, April 9, 2021
Register now and catch up on previous clinician calls.
Deadline Extended! Assemblies Mentoring Program
The Assemblies Mentoring Program is now hybrid! Mentors and mentees can connect virtually or in-person at ATS 2022.
The Assemblies Mentoring Program is designed to foster mentoring connections through individualized attention. It matches mentees with mentors based on their areas of interest. Mentoring is open to all ATS members.
Deadline: April 10, 2022
Learn more!
New Trials Listed on ATS Clinical Trial Resources Site
Two new trials by Sanofi have listed on the ATS Clinical Trial Resources page and are currently recruiting!
ATLAS (NCT05097287) is a double-blind, placebo-controlled, parallel group, multicenter, study designed to evaluate the role of dupilumab in preventing or slowing LFD over a period of three years versus standard of care therapy.
The goal of the phase 4, randomized, double-blind, placebo-controlled VESTIGE study (NCT04400318) is to assess dupilumab's effect on lung function and structural airway changes using functional respiratory imaging (FRI), a novel technology using high-resolution CT (HRCT) scans to produce 3D visualizations and quantify airway structure and function.
Please visit the ATS Clinical Trial Resources page to connect to current, ongoing clinical trials in pulmonary, critical care, and sleep medicine being conducted by participating pharmaceutical and device companies. You can learn more on our website, or by contacting Vlada O’Hara for additional information.
